GPX Medical AB (publ) publicerar idag delårsrapport januari – september 2021. Läs pressmeddelandet och rapporten i sin helhet här: Delårsrapport januari – september 2021


Aktieägare och intressenter är varmt välkomna till bolagets rapportpresentation den 9 november 2021 kl. 14.00. För anmälan och videolänk, kontakta Marketing and Communication Lead Freja Bremborg


Rapportpresentationen kommer att finnas tillgänglig i efterhand på bolagets hemsida.

About GPX Medical

GPX Medical AB (publ) is revolutionizing neonatal intensive care with NEOLA®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. NEOLA® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, GPX Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:


GPX Medical AB (publ)
Ideon Science Park
Scheelevägen 27
223 63 Lund

Organization number: 559069-9012